NBO Pharma Inc. · CIK 2103906
NBO Pharma Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
2
Original notices
2
Amendments
0
Activity
Jan 22, 2026
through Nov 9, 2026
through Nov 9, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Jan 22, 2026 · D | Nov 9, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $7,640,217 | $7,000,000 | $-640,217 |
| Reported amount sold | $7,640,217 | $238,000 | $-7,402,217 |
| Reported investor count | — | 5 | — |
| Reported minimum investment | $10,000 | $0 | $-10,000 |
Earlier SEC source: 0002103906-26-000001 · Later SEC source: 0002103906-26-000002
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $7,000,000
- Reported exemptions
- Rule 506(c)
- Reported amount sold
- $238,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Form D filings (2)
-
0002103906-26-000002D · Nov 9, 2026 · PharmaceuticalsOffering: $7,000,000Sold: $238,000
Compared with 0002103906-26-000001:
- Reported offering amount: $7,640,217 → $7,000,000
- Reported amount sold: $7,640,217 → $238,000
- Reported investor count: Unavailable → 5
- Reported minimum investment: $10,000 → $0
-
0002103906-26-000001D · Jan 22, 2026 · PharmaceuticalsOffering: $7,640,217Sold: $7,640,217